خلاصہ: November 13 2025 – Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings
November 13 2025 – Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings
admin
Thu, 11/13/2025 – 11:37
admin
Thu, 11/13/2025 – 11:37
Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings
Gilead Sciences board
Metsera shareholders vote for up to $10 billion acquisition by Pfizer
Pfizer board
Novo Nordisk faces rare shareholder rebuke over board shake-up
Novo Nordisk board
FDA unveils new regulatory roadmap for bespoke drug therapies
Pharma/Biotech General Discussion board
*please scroll down for all the latest news*
Layoff discussions
Check open job listings in your area
Click here to the top four headlines in your inbox Mon-Fri (free)
learn about pharmaceutical fraud
learn about the False Claims Act
image